The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patients

2015

J A I D S , Volume 68 - Issue 1 p. 36- 39

Additional Metadata
Keywords	Antiretroviral therapy, HIV-1, Nevirapine, Pharmacokinetics, Rilpivirine, Safety
Persistent URL	hdl.handle.net/1765/86505
Journal	J A I D S
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Rokx, C, Blonk, M.I, Verbon, A, Burger, D.M, & Rijnders, B.J.A. (2015). The efficacy, pharmacokinetics, and safety of a nevirapine to rilpivirine switch in virologically suppressed HIV-1-infected patients. J A I D S, 68(1), 36–39. Retrieved from http://hdl.handle.net/1765/86505

Publication